CYP19A1 and cancer: Not only do DVLs bind to multiple tissue-specific aromatase promoters that are aberrantly activated in cancer, but the role of DVL-1 vs. DVL-3 appears to play a promoter-specific and cell- type dependent role that can lead to either activation or repression of CYP19A1 transcripts (Figure 5D).